359 related articles for article (PubMed ID: 17259330)
1. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects.
Myzak MC; Tong P; Dashwood WM; Dashwood RH; Ho E
Exp Biol Med (Maywood); 2007 Feb; 232(2):227-34. PubMed ID: 17259330
[TBL] [Abstract][Full Text] [Related]
2. Dietary histone deacetylase inhibitors: from cells to mice to man.
Dashwood RH; Ho E
Semin Cancer Biol; 2007 Oct; 17(5):363-9. PubMed ID: 17555985
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
Myzak MC; Karplus PA; Chung FL; Dashwood RH
Cancer Res; 2004 Aug; 64(16):5767-74. PubMed ID: 15313918
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.
Myzak MC; Dashwood WM; Orner GA; Ho E; Dashwood RH
FASEB J; 2006 Mar; 20(3):506-8. PubMed ID: 16407454
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
Myzak MC; Hardin K; Wang R; Dashwood RH; Ho E
Carcinogenesis; 2006 Apr; 27(4):811-9. PubMed ID: 16280330
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
7. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.
Nian H; Delage B; Ho E; Dashwood RH
Environ Mol Mutagen; 2009 Apr; 50(3):213-21. PubMed ID: 19197985
[TBL] [Abstract][Full Text] [Related]
8. The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
Abbaoui B; Telu KH; Lucas CR; Thomas-Ahner JM; Schwartz SJ; Clinton SK; Freitas MA; Mortazavi A
J Proteomics; 2017 Mar; 156():94-103. PubMed ID: 28132875
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
Rajendran P; Delage B; Dashwood WM; Yu TW; Wuth B; Williams DE; Ho E; Dashwood RH
Mol Cancer; 2011 May; 10():68. PubMed ID: 21624135
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo.
Singh AV; Xiao D; Lew KL; Dhir R; Singh SV
Carcinogenesis; 2004 Jan; 25(1):83-90. PubMed ID: 14514658
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity.
Jiang LL; Zhou SJ; Zhang XM; Chen HQ; Liu W
Biomed Pharmacother; 2016 Mar; 78():74-80. PubMed ID: 26898427
[TBL] [Abstract][Full Text] [Related]
12. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.
Ho E; Clarke JD; Dashwood RH
J Nutr; 2009 Dec; 139(12):2393-6. PubMed ID: 19812222
[TBL] [Abstract][Full Text] [Related]
13. The dietary histone deacetylase inhibitor sulforaphane induces human beta-defensin-2 in intestinal epithelial cells.
Schwab M; Reynders V; Loitsch S; Steinhilber D; Schröder O; Stein J
Immunology; 2008 Oct; 125(2):241-51. PubMed ID: 18373608
[TBL] [Abstract][Full Text] [Related]
14. Multi-targeted prevention of cancer by sulforaphane.
Clarke JD; Dashwood RH; Ho E
Cancer Lett; 2008 Oct; 269(2):291-304. PubMed ID: 18504070
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane retards the growth of UM-UC-3 xenographs, induces apoptosis, and reduces survivin in athymic mice.
Wang F; Shan Y
Nutr Res; 2012 May; 32(5):374-80. PubMed ID: 22652377
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon.
Rajendran P; Dashwood WM; Li L; Kang Y; Kim E; Johnson G; Fischer KA; Löhr CV; Williams DE; Ho E; Yamamoto M; Lieberman DA; Dashwood RH
Clin Epigenetics; 2015; 7(1):102. PubMed ID: 26388957
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effect.
Zanichelli F; Capasso S; Cipollaro M; Pagnotta E; Cartenì M; Casale F; Iori R; Galderisi U
Age (Dordr); 2012 Apr; 34(2):281-93. PubMed ID: 21465338
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice.
Kanematsu S; Yoshizawa K; Uehara N; Miki H; Sasaki T; Kuro M; Lai YC; Kimura A; Yuri T; Tsubura A
Oncol Rep; 2011 Sep; 26(3):603-8. PubMed ID: 21617865
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells.
Pei Y; Wu B; Cao Q; Wu L; Yang G
Toxicol Appl Pharmacol; 2011 Dec; 257(3):420-8. PubMed ID: 22005276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
